Allergy Nanomedicine

Nanomedicine includes the development of nanoparticles, nanostructured surfaces and nanoanalytical techniques for molecular diagnostics, treatment, follow up and therapy of diseases (theranostics), as well as integrated medical nanosystems, which, in future, may perform monitoring and complex repairs in the body at the cellular level. Nanotechnology considers cells as a complex system of interacting nanoengines. Visionary concepts suggest the construction and control of artificial cells using engineered nanodevices and nanostructures for medical applications.

Global Nanomedicine Market accounted for $111,912 million in 2016, and is anticipated to reach $261,063 million by 2023, registering a CAGR of 12.6% from 2017 to 2023. Nanomedicine is one of the applications of nanotechnology used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine uses nanoscale manipulation of materials to improve medicine delivery. Thus, nanomedicine has facilitated the treatment against various diseases. Nanomedicine is in nascent stage, as several products are in the development phase.